ScholarIQanswers from OpenAlex & ORCID
Mark R. Gilbert
ResearcherPublications, citations & collaboration network
Mark R. Gilbert is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Mark R. Gilbert have?
ScholarIQindexed works
Mark R. Gilbert has 1,202 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Mark R. Gilbert have?
ScholarIQcitation count
Mark R. Gilbert has 50,713 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Mark R. Gilbert?
ScholarIQh-index
Mark R. Gilbert has an h-index of 105 in OpenAlex.
What is the i10-index of Mark R. Gilbert?
ScholarIQi10-index
Mark R. Gilbert has an i10-index of 417 in OpenAlex.
What is the ORCID of Mark R. Gilbert?
ScholarIQorcid
The ORCID for Mark R. Gilbert is on the source record.
What is the OpenAlex record for Mark R. Gilbert?
ScholarIQopenalex
The OpenAlex for Mark R. Gilbert is on the source record.
What are the most-cited papers on Mark R. Gilbert?
ScholarIQmost cited works
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
Mark R. Gilbert, James J. Dignam, Terri S. Armstrong, Jeffrey S. Wefel, Deborah T. Blumenthal, Michael A. Vogelbaum, Howard Colman, Arnab Chakravarti, Stephanie L. Pugh, Minhee Won, Robert Jeraj, Paul D. Brown, Kurt A. Jaeckle, David Schiff, Volker W. Stieber, David Brachman, Maria Werner‐Wasik, Ivo W. Tremont‐Lukats, Erik P. Sulman, Kenneth Aldape, Walter J. Curran, Minesh P. Mehta
Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial
Mark R. Gilbert, Meihua Wang, Kenneth Aldape, Roger Stupp, Monika E. Hegi, Kurt A. Jaeckle, Terri S. Armstrong, Jeffrey S. Wefel, Minhee Won, Deborah T. Blumenthal, Anita Mahajan, Christopher J. Schultz, Sara Erridge, Brigitta G. Baumert, Kristen I. Hopkins, Tzahala Tzuk-Shina, Paul D. Brown, Arnab Chakravarti, Walter J. Curran, Minesh P. Mehta
Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma
Jan C. Buckner, Edward G. Shaw, Stephanie L. Pugh, Arnab Chakravarti, Mark R. Gilbert, Geoffrey Barger, Stephen W. Coons, Peter E. Ricci, Dennis E. Bullard, Paul D. Brown, K. Stelzer, David Brachman, John H. Suh, Christopher J. Schultz, Jean-Paul Bahary, Barbara J. Fisher, Harold Kim, Albert Murtha, Erica H. Bell, Minhee Won, Minesh P. Mehta, Walter J. Curran
Immunotherapy response assessment in neuro-oncology: a report of the RANO working group
Hideho Okada, Michael Weller, Raymond Y. Huang, Gaetano Finocchiaro, Mark R. Gilbert, Wolfgang Wick, Benjamin M. Ellingson, Naoya Hashimoto, Ian F. Pollack, Alba A. Brandes, Enrico Franceschi, Christel Herold‐Mende, Lakshmi Nayak, Ashok Panigrahy, Whitney B. Pope, Robert M. Prins, John H. Sampson, Patrick Y. Wen, David A. Reardon
Differential Sensitivity of Glioma- versus Lung Cancer–Specific EGFR Mutations to EGFR Kinase Inhibitors
Igor Vivanco, H. Ian Robins, Daniel Rohle, Carl Campos, Christian Grommes, Phioanh L. Nghiemphu, Sara Kubek, Barbara Oldrini, Milan G. Chheda, Nicolas A. Yannuzzi, Hui Tao, Shaojun Zhu, Akio Iwanami, Daisuke Kuga, Julie Dang, Alicia Pedraza, Cameron Brennan, Adriana Heguy, Linda M. Liau, Frank S. Lieberman, W.K. Alfred Yung, Mark R. Gilbert, David A. Reardon, Jan Drappatz, Patrick Y. Wen, Kathleen R. Lamborn, Susan M. Chang, Michael D. Prados, Howard A. Fine, Steve Horvath, Nian Wu, Andrew B. Lassman, Lisa M. DeAngelis, William H. Yong, John G. Kuhn, Paul S. Mischel, Minesh P. Mehta, Timothy F. Cloughesy, Ingo K. Mellinghoff